Correction
Published on 18 May 2022
Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination
Pathology and Oncology Research
doi 10.3389/pore.2022.1610517
Type at least 3 characters
2,897 articles
Articles
Original Research
Published on 16 May 2022
Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response
Pathology and Oncology Research
doi 10.3389/pore.2022.1610322
Original Research
Published on 11 May 2022
NTRK Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects
Pathology and Oncology Research
doi 10.3389/pore.2022.1610423
Original Research
Published on 11 May 2022
Whole-Exome Sequencing Could Distinguish Primary Pulmonary Squamous Cell Carcinoma From Lung Metastases in Individuals With Cervical Squamous Cell Carcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610325
Systematic Review
Published on 10 May 2022
Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis
Pathology and Oncology Research
doi 10.3389/pore.2022.1610266
Case Report
Published on 10 May 2022
Case Report: Recurrent Malignant Struma Ovarii With Hyperthyroidism and Metastases, A Rare Case Report and Review of the Literature
Pathology and Oncology Research
doi 10.3389/pore.2022.1610221
Original Research
Published on 02 May 2022
Novel Diagnostic Value of Driver Gene Transcription Signatures to Characterise Clear Cell Renal Cell Carcinoma, ccRCC
Pathology and Oncology Research
doi 10.3389/pore.2022.1610345
Review
Published on 29 Apr 2022
Senescence-Associated miRNAs and Their Role in Pancreatic Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610156
Case Report
Published on 29 Apr 2022
Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia
Pathology and Oncology Research
doi 10.3389/pore.2022.1610338
Original Research
Published on 28 Apr 2022
The Diagnostic Significance of CXCL13 in M2 Tumor Immune Microenvironment of Human Astrocytoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610230
Original Research
Published on 27 Apr 2022
High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610315
Original Research
Published on 27 Apr 2022
Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
Pathology and Oncology Research
doi 10.3389/pore.2022.1610294
Brief Research Report
Published on 22 Apr 2022
HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab
Pathology and Oncology Research
doi 10.3389/pore.2022.1610297
Letter to the Editor
Published on 22 Apr 2022
Blocking the Metabolic Switch Toward Cytosolic 1C Flux: A Novel Therapeutic Approach for Tumors With Low SLC19A1 Expression
Pathology and Oncology Research
doi 10.3389/pore.2022.1610337
Original Research
Published on 20 Apr 2022
Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study
Pathology and Oncology Research
doi 10.3389/pore.2022.1610280
Original Research
Published on 19 Apr 2022
Pathological Changes and Expression of JAK-STAT Signaling Pathway Hallmark Proteins in Rat Retinas at Different Time Points After Retinal Ischemia Reperfusion Injury
Pathology and Oncology Research
doi 10.3389/pore.2022.1610385